Actualités Biotalys - BTLS | Actions Euronext

Outils de qualité professionnelle, pour des investisseurs individuels.

Results of the Ordinary Shareholders’ Meeting

Results of the Ordinary Shareholders’ Meeting Regulated InformationGhent, Belgium, April 22, 2025 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS...

Biotalys to Appoint Toni Bucci to its Board of Directors

Biotalys to Appoint Toni Bucci to its Board of Directors Seasoned Agriculture and Biotech Executive With a Passion to Feed the World...

Invitation to the ordinary general shareholders meeting

Invitation to the ordinary general shareholders meeting Ghent, BELGIUM, March 21, 2025 (GLOBE NEWSWIRE) -- Press release – regulated information...

Biotalys Reports Full-Year 2024 Financial Results and Business Highlights

Biotalys Reports Full-Year 2024 Financial Results and Business Highlights Ghent, BELGIUM, March 19, 2025 (GLOBE NEWSWIRE) -- Press release –...

Biotalys Achieves Strong Results in Field Trials with Second Biofungicide

Biotalys Achieves Strong Results in Field Trials with Second Biofungicide BioFun-6 Candidate Shows Excellent Efficacy with Increased Potency...

Information on the total number of voting rights and shares

Information on the total number of voting rights and shares Regulated InformationGhent, BELGIUM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Biotalys NV...

Biotalys Provides Regulatory Review Update on EVOCA

Biotalys Provides Regulatory Review Update on EVOCA Dutch Regulatory Authority CTGB Recommends European Approval; U.S. Review OngoingGhent...

Publication of transparency notifications

Publication of transparency notifications Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares...

Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer Company Expands Senior Leadership Team with Experienced Agriculture...

Biotalys announces Closing of Private Placement

Biotalys announces Closing of Private Placement Information on the total number of voting rights and sharesGhent, BELGIUM, Oct. 16, 2024 (GLOBE...

Biotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors

Biotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors Additional...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Abonnez-vous à un compte ADVFN en remplissant le formulaire ci-dessous!

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Biotalys (BTLS)

Outils de qualité professionnelle, pour des investisseurs individuels.

BTLS Actualités

Results of the Ordinary Shareholders’ Meeting

Biotalys to Appoint Toni Bucci to its Board of Directors

Invitation to the ordinary general shareholders meeting

Biotalys Reports Full-Year 2024 Financial Results and Business Highlights

Biotalys Achieves Strong Results in Field Trials with Second Biofungicide

Information on the total number of voting rights and shares

Biotalys Provides Regulatory Review Update on EVOCA

Publication of transparency notifications

Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

Biotalys announces Closing of Private Placement

Biotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors

Biotalys Expands R&D Pipeline with New Biofungicide Program

Biotalys Granted Patents for EVOCA in Both Europe and the United States

Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

Biotalys Reports Half-Year 2024 Financial Results and Business Highlights

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Biotalys (BTLS) Actualités

Biotalys (BTLS)

Outils de qualité professionnelle, pour des investisseurs individuels.

BTLS Actualités

Results of the Ordinary Shareholders’ Meeting

Biotalys to Appoint Toni Bucci to its Board of Directors

Invitation to the ordinary general shareholders meeting

Biotalys Reports Full-Year 2024 Financial Results and Business Highlights

Biotalys Achieves Strong Results in Field Trials with Second Biofungicide

Information on the total number of voting rights and shares

Biotalys Provides Regulatory Review Update on EVOCA

Publication of transparency notifications

Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

Biotalys announces Closing of Private Placement

Biotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors

Biotalys Expands R&D Pipeline with New Biofungicide Program

Biotalys Granted Patents for EVOCA in Both Europe and the United States

Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

Biotalys Reports Half-Year 2024 Financial Results and Business Highlights

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Abonnez-vous à un compte ADVFN en remplissant le formulaire ci-dessous!

Supprimer les publicités